TPEx - Taipei Exchange

10/20/2021 | Press release | Distributed by Public on 10/20/2021 01:25

TPEx imposes penalty on DR.Chip Biotechnology Incorporation for violation of TPEx rules and material information disclosure.

Taipei Exchange (TPEx) announces that DR.Chip Biotechnology Incorporation (code: 4131) reduced 40 percent of its shareholding in a major subsidiary, however, the company failed to follow TPEx Rules Governing Securities Trading on the TPEx and TPEx Procedures for Verification and Disclosure of Material Information of Companies with TPEx Listed Securities. TPEx imposes a penalty of NT$30,000 on the company.